News
Threads by Meta Platforms Expands to Europe
The microblogging app Threads, launched by Meta Platforms, expands to Europe, providing users with more countries to access the app and improved features. Adver...
Vivendi Considers Splitting into Three Businesses
Vivendi plans to explore splitting into three businesses - Canal+, Havas, and an investment company - to address valuation challenges and enhance growth. The re...
Market Update: U.S. Futures Show Positive Indicators
U.S. futures for the S&P 500 and Dow Jones display promising signs. European markets reflect mixed performances, while Asian markets show diverse results.
Air France-KLM Expects Profitability Increase
Air France-KLM projects a significant increase in profitability and operating margin exceeding 8% by 2026-28. The company focuses on implementing its transforma...
November Retail Sales Expected to Decline Due to Gasoline Prices
November's retail sales are predicted to decline due to the impact of gasoline prices. Despite challenges, American consumers have maintained their spending hab...
European Central Bank and Bank of England Expected to Keep Interest Rates Unchanged
The European Central Bank and the Bank of England are predicted to keep interest rates unchanged, offering forecasts for inflation and growth. Amid stronger U.S...
Costco Wholesale Set to Report Fiscal First-Quarter Results
Costco Wholesale is set to release its first-quarter results, including net income, revenue, and adjusted earnings. Key things to watch include membership fee i...
Editas Medicine to License Cas9 Gene Editing Technology to Vertex Pharmaceuticals
Editas Medicine has entered into a licensing agreement with Vertex Pharmaceuticals for the use of its Cas9 gene editing technology in ex vivo gene editing medic...
Mortgage Demand Surges as Rates Hit Lowest Level
Mortgage rates have reached their lowest levels since July, leading to increased demand for mortgages. Both buying and refinancing activity have seen a signific...
Reshape Lifesciences Receives FDA Approval for Modified Obesity Treatment
Reshape Lifesciences has received FDA approval for its modified treatment for obesity, resulting in a 43% surge in shares. Categories: Health, Pharmaceuticals,...